Portfolio Categories News & Media
-1
archive,tax-portfolio_category,term-news-media,term-94,bridge-core-2.5.8,ajax_fade,page_not_loaded,,qode-theme-ver-24.3,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.4.2,vc_responsive

Archive

CHARLOTTESVILLE, VA, January 10, 2017 -- ADial Pharmaceuticals LLC, a developer of novel and effective gene-specific medications to treat addiction and related disorders, today announced that it has been granted a patent by the United States Patent and Trademark Office entitled “Molecular Genetic Approach to...

ADial Pharmaceuticals LLC (“ADial”), a developer of pharmaceutical products focused on novel and effective treatments for addictions and related disorders, announced the promotion of Joseph Truluck from Vice President of Operations and Finance to Chief Operating and Chief Financial Officer.   Joseph Truluck has served as Vice...